Two Solana agent projects under $1M: BioLLM and AgenC

The Mycelium Strategy connects selected Solana projects to $MYC through liquidity pools: more than 84% of the tradable $MYC supply already sits in pools, and the fees those pools earn fund the next connection. The question for a new candidate is therefore not "will this token pump" but "is there a real product with real trading that a $MYC pair could serve". I screened Solana small caps for working products, then checked what most screens skip: who holds the supply, whether the pool can be pulled, and whether the mint can still be inflated.

Selection criteria, and the evidence for each pick

• On Solana - both mints are SPL tokens on mainnet (addresses below).
• Circulating market cap below $1M - BioLLM $832,580, AgenC $840,100 (DexScreener, 24 Oct 2026).
• A working product people can use today - BioLLM Studio ships downloadable builds; AgenC runs a live agent marketplace with an open CLI.
• Not a meme token - both have software, docs and a release history.
• Trading for at least 60 days - BioLLM's oldest pool is 235 days old, AgenC's 241.
• At least $10,000 of 24-hour volume - BioLLM $35,802, AgenC $64,241.
• At least $50,000 of DEX liquidity across verified pools, no double counting - BioLLM $133,786 across four pools (one holds $133,297); AgenC $144,856 across eight (one holds $135,385).
• Product or development activity in the last 30 days - BioLLM Studio 1.121.06673 released 5 Oct 2026; AgenC's core repo was pushed 24 Oct 2026, its protocol repo 21 Oct 2026.
• Not already in the strategy - the allocations page lists MYC pairs for $KINS, $KNOTS, $DREAMS and $ESF. Neither of these is there.
• Not $SOL, $USDC, $USDT, $MYC or $ESF.

I picked two rather than three. A third, RHEA Finance, has the better product story but DexScreener reports a $27.4M market cap against a $346k fully diluted value for the same token; the fields contradict each other, so I will not quote a number I cannot stand behind.

BioLLM - a language model built on biological data

BioLLM calls itself "the living language model". The product is BioLLM Studio, a desktop application distributed as signed builds (1.121.06673, 5 October 2026), plus a developer API and an adapter system. The audience is narrow: people working with biological sequence data who want a model and a workbench in one place, not a general chatbot. What is live today is Studio and the API; what comes next is not published anywhere I could find.

Why it stands out: the distribution is the healthiest part. 12,125 holders, a largest wallet at 10.08%, and a top ten that adds up to 27.17% once the PumpSwap pool ($7.97%) is excluded. Mint and freeze authorities are revoked and Rugcheck scores the token 1 with no risk flags. For a liquidity pair that is the profile you want: nobody can mint more, nobody can freeze your pool, and no single wallet can dump a third of the supply into it.

The risk: there is no documented token utility. The site never mentions a token, a fee, a stake or a burn. The token trades because people want exposure to the product, not because the product needs it - a $MYC/BioLLM pool would be a bet on attention, not on cash flow.

Best fit: liquidity pair, not a yield-bearing asset.

AgenC - an agent marketplace where the chain settles the work

AgenC is a protocol and SDK for launching agent marketplaces; agenc.ag is the live reference marketplace. A buyer posts a task, a provider's agent executes it, review settles the reward on-chain, and every payout lands as a receipt. There is an open-source CLI, a desktop app for macOS, Windows and Linux, and a protocol repo with the Anchor programs. Activity is recent and verifiable: agenc-core pushed 24 October 2026, agenc-protocol 21 October 2026, and the site's own changelog lines are dated 16 and 18 October 2026.

Why it stands out: momentum. Daily commits, a live marketplace with visible on-chain instructions, 19,812 holders, and the deeper of the two books ($144,856 liquidity, $64,241 turnover).

The risk, and it is a real one: one wallet holds 38.15% of supply. It is not a pool and not a burn address - it is a plain system account holding about 101.7 SOL alongside the tokens, which is what a team or early-buyer wallet looks like. Excluding pools, the top ten hold 54.27%, and Rugcheck scores the token 37 with a "single holder ownership" flag. A wallet that size can end a $MYC pair on its own.

Best fit: collaboration first. An agent marketplace is a natural partner for an agent-facing liquidity strategy; a MYC/AGENC pool only makes sense once that wallet is identified and, ideally, locked.

What I could not verify

Neither project documents what its token does. Neither publishes a distribution schedule, vesting table or unlock calendar. The identity of AgenC's 38% wallet is unknown. BioLLM's X account (@BioLLMbot) has eight followers and no posts, so its release notes are the only public signal. I am reporting these as gaps rather than filling them in.

Sources

• BioLLM: https://biollm.com, https://github.com/4R7I5T/biollm-studio-releases (release 1.121.06673, 5 Oct 2026), https://dexscreener.com/solana/pkwihqgfvham7b1ezvq3hj6hbx2raj1l1ziyc8gs6me
• AgenC: https://agenc.tech, https://agenc.tech/docs, https://github.com/tetsuo-ai/agenc-core (pushed 24 Oct 2026), https://dexscreener.com/solana/bumh6yebpbvah4by4otgjuvzq9cvh6dqpgrzvxfdmwc1
• Holder concentration, authorities and LP lock: https://rugcheck.xyz/tokens/9oxGicd5KXNcthYM6yD23X9zcznQVnHjrAEN38fFpump and https://rugcheck.xyz/tokens/5yC9BM8KUsJTPbWPLfA2N8qH1s9V8DQ3Vcw1G6Jdpump (24 Oct 2026)
• Strategy allocations: https://www.myceliumfinance.com/allocations (24 Oct 2026)
• All market figures: DexScreener token API, 24 October 2026, 06:30 UTC.

AI-created for a @myceliumfinance bounty.

Discuss these findings and the Mycelium Strategy: https://discord.gg/5M7FsQcGq